Patient have uterus adenomyosis and endometriosis patients platelet are 6lac and have fever too
adenomyosis endometriosis thrombocytosis platelets
endometriosis thrombocytosis platelets
endometriosis inflammation reactive thrombocytosis elevated platelets
endometriosis adenomyosis thrombocytosis 6 lakh platelets fever significance
adenomyosis endometriosis management treatment 2024
| Cause | Notes |
|---|---|
| Active inflammatory flare of endometriosis/adenomyosis | Low-grade fever is possible during perimenstrual flares due to intense local inflammation and prostaglandin release |
| Superimposed infection / PID | Pelvic inflammatory disease can co-occur; rule out with cultures, WBC differential |
| Post-procedural infection | If patient had recent surgery or IUD insertion |
| Malignancy (rare) | Endometrial cancer or rare transformation; especially if fever is persistent/unexplained |
| Autoimmune / connective tissue disease | Can coexist with endometriosis; causes fever + thrombocytosis together |
| Deep vein thrombosis / thromboembolism | Although reactive thrombocytosis itself doesn't increase clot risk, the underlying inflammation does |
| Treatment Category | Options |
|---|---|
| Medical (first-line) | Combined OCP (cyclic or continuous), levonorgestrel-releasing IUD (Mirena), progestins (norethisterone, medroxyprogesterone) |
| GnRH agonists | Leuprolide, triptorelin - effective but limit to 6 months due to bone loss; add-back therapy with norethisterone |
| GnRH antagonists (newer) | Elagolix, relugolix - oral, reversible suppression; good evidence for both adenomyosis and endometriosis |
| NSAIDs | Mefenamic acid, naproxen - for pain and dysmenorrhea; also reduce prostaglandin-driven inflammation |
| Surgical | Hysterectomy is definitive for adenomyosis; conservative surgery (excision of endo lesions) for endometriosis in women wanting fertility; uterine artery embolization (UAE) is an option |
Can bilateral endiometrioc cyst cause fever with chills
bilateral endometrioma endometriotic cyst fever chills rupture infection mechanism clinical
endometrioma rupture fever peritonitis infection
infected endometrioma secondary infection abscess fever chills sepsis clinical presentation
infected endometrioma abscess management antibiotics surgery
| Mechanism | Fever Pattern | Key Feature | Urgency |
|---|---|---|---|
| Cyst rupture | Sudden high fever with rigors | Acute abdomen, peritoneal signs | Emergency - surgical |
| Infected endometrioma (abscess) | High fever, chills, progressive | Adnexal mass + WBC raised | Urgent - IV antibiotics ± drainage |
| Superimposed PID/TOA | High fever, chills | Bilateral tenderness + discharge | Urgent - IV antibiotics |
| Chronic inflammation flare | Low-grade fever only | Cyclic pattern, no rigors | Non-emergency - medical Rx |
bilateral endometrioma 44 year old woman management guidelines surgery hormonal treatment options 2024
bilateral endometrioma ovarian cystectomy recurrence hormonal suppression
"BULKY BOTH OVARIES WITH COMPLEX CYSTIC LESIONS. ON ULTRASOUND CORRELATION FINE ECHOES ARE SEEN WITHIN --- LIKELY BILATERAL ENDOMETRIOTIC CYSTS." Kindly correlate clinically.
| Finding | Clinical Significance |
|---|---|
| Bilateral bulky ovaries | Severe/advanced endometriosis (stage III-IV) |
| Complex cystic lesions both sides | High disease burden, both ovaries involved |
| "Likely bilateral endometriotic cysts" | Confirms endometrioma as source of fever, thrombocytosis, pelvic pain |
| Age 44, female | Perimenopausal - adds urgency; ovarian reserve likely already reduced |
| Drug | Dose | Purpose |
|---|---|---|
| Dienogest 2 mg | Once daily oral | Progestin - reduces endometrioma size, controls pain, suppresses disease |
| OR Combined OCP | Cyclic or continuous | Hormonal suppression |
| OR GnRH agonist (Leuprolide 3.75 mg IM) | Monthly injection | Stronger suppression; max 6 months; add norethisterone add-back |
| NSAIDs (Mefenamic acid / Naproxen) | With meals | For pain/dysmenorrhea |
| Iron supplementation | If iron deficient | Correct anaemia from heavy bleeding, also helps reduce reactive thrombocytosis |